Global Thalassemia Treatment Market is estimated to be US$ 14.7 billion by 2030 with a CAGR of 10.40% during the forecast period - By PMI Covina, CA, April 30, 2021 (GLOBE NEWSWIRE) -- The Global Thalassemia Treatment Market accounted for US$ 2.3 billion in 2020 and is estimated to be US$ 14.7 billion by 2030 and is anticipated to...

Global Transthyretin Amyloidosis Treatment Market–Analysis and Demand with Forecast Overview to 2029 - by PMI Covina CA, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Robust pipeline of transthyretin amyloidosis treatment drugs is one of the major factors that is expected to propel growth of the market over the...

FACIT and Triphase Accelerator Announce New Partnership with Celgene for First-in-class WDR5 Leukemia Therapy TORONTO, ON, Jan. 29, 2019 (GLOBE NEWSWIRE) -- Triphase Accelerator, together with its majority shareholder FACIT, today announced a new strategic collaboration with Celgene for a first-in-class...

Robbins Arroyo LLP is Investigating the Officers and Directors of Celgene Corporation (CELG) on Behalf of Shareholders SAN DIEGO and SUMMIT, N.J., Sept. 26, 2014 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of Celgene Corporation breached...